Crossmark

Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target

Crossref DOI link: https://doi.org/10.1016/j.medcle.2015.04.002

Published Print: 2015-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Guijarro, Carlos

Ruilope, Luis Miguel
License Information

Text and Data Mining valid from 2015-07-01
More Information

This article is maintained by: Elsevier

Article Title: Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2015.04.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2015.04.007

Content Type: article

Copyright: Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below